CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 1, January/February 2014
26
AFRICA
References
1.
Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel
HC,
et al.
The effect of aortic valve replacement on survival.
Circulation
1982;
6
: 1105–1110.
2.
Carabello BA, Paulus WJ. Aortic stenosis.
Lancet
2009;
373
: 956e66.
3.
Grunkemeier GL, Jin R, Starr A. Prosthetic heart valves: objective
performance criteria versus randomized clinical trial.
Ann Thorac Surg
2006;
82
: 776–780.
4.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang
OW,
et al
. A prospective survey of patients with valvular heart disease
in Europe: The Euro heart survey on valvular heart disease.
Eur Heart
J
2003;
24
: 1231–1243.
5.
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG,
et
al
. Transcatheter aortic-valve implantation for aortic stenosis in patients
who cannot undergo surgery.
N Engl J Med
2010;
363
: 1597–1607.
6.
Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas
PS,
et al.
Transcatheter aortic-valve replacement for inoperable severe
aortic stenosis.
N Engl J Med
2012;
366
: 1696–1704.
7.
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG,
et al
. Transcatheter and surgical aortic-valve replacement in high-risk
patients.
N Engl J Med
2011;
364
: 2187–2198.
8.
Kodali SK , Williams MR, Smith CR, Svensson LG, Webb JG, Makkar
RR,
et al
. Two-year outcomes after transcatheter or surgical aortic-valve
replacement.
N Engl J Med
2012;
366
: 1686–1695.
9.
Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak
J,
et al.
Cost Effectiveness of transcatheter aortic valve replace-
ment compared with standard care among inoperable patients with
severe aortic stenosis: Results from the PARTNER trial (Cohort B).
Circulation
2012;
125
: 1076–1077.
10. Watt M, Mealing S, Eaton J, Piazza N, Moat N, Brasseur P,
et al
.
Cost-effectiveness of transcatheter aortic valve replacement in patients
ineligible for conventional aortic valve replacement.
Heart (Br Med J)
2011;
98
(5): 370–376.
11. Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov
model for selection of aortic valve replacement versus transcatheter
aortic valve implantation (without replacement) in high-risk patients.
Am J Cardiol
2012;
109
(9): 1326–1333.
12. SouthAfrican consumer price index. Governmental Statistics Department.
.
13. Venables WN, Ripley BD.
Modern Applied Statistics
, 4th edn. New
York: Springer, 2002. ISBN 0-387-95457-0.
14. R Development core team.
R: A Language and Environment for
Statistical Computing.
Vienna: R Foundation for Statistical Computing,
2008. ISBN 3-900051-07-0, URL
15. Miller DG, Blackstone EH, Mack MJ, Svensson LG, Kodali SK,
Kapadia S,
et al
. TAVR vs. sAVR: Occurrence, hazard, risk factors, and
consequences of neurological events in the PARTNER trial.
IEEE TSC
J
2012; 832-843.e13.
16. Thourani VH, Ailawadi G, Szeto WY, Dewey TM, Guyton RA, Mack
MJ,
et al
. Outcomes of surgical aortic valve replacement in high-risk
patients: a multi-institutional study.
Ann Thorac Surg
2011;
91
: 49–56.
17. Wenaweser P, Pilgrim T, Kadner A, Huber C, Stortecky S, Buellesfeld
L,
et al
. Clinical outcomes of patients with severe aortic stenosis at
increased surgical risk according to treatment modality.
J Am Coll
Cardiol
2011;
58
(21): 2151–2162.
18. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a
combined comorbidity index.
J Clin Epidemiol
1994;
47
: 1245–1251.
19. Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance
of Charlson and Elixhauser comorbidities in ICD9 and ICD10 adminis-
trative databases.
BMC Health Serv Res
2008;
8
: 12.
20. Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a
predictor of long-term outcome after surgery for nonsmall cell lung
cancer.
Eur J Cardiothorac Surg
2003;
28
: 759–762.
21. Nunez JE, Nunez E, Facila L, Bertomeu V, Llacer A, Bodi V,
et al
.
Prognostic value of Charlson comorbidity index at 30 days and 1 year
after acute myocardial infarction.
Rev Esp Cardiol
2004;
57
: 842–849.
22. Goldstein LB, Samsa GP, Matchar DB, Horner RD. (2004). Charlson
index comorbidity adjustment for ischemic stroke outcome studies.
Stroke
2004;
35
: 1941–1945.
23. Murray SB, Bates DW, Ngo L, Ufberg JW, Shapiro NI. Charlson index
is associated with one-year mortality in emergency department patients
with suspected infection.
Acad Emerg Med
2006;
13
(5): 530–536. Epub
2006 Mar 21.
24. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreuil K,
Fajadet J,
et al
. Registry of transcatheter aortic-valve implantation in
high-risk patients.
N Engl J Med
2012;
366
: 1705–1715.
25. Arnoutakis GJ, George TJ, Alejo DE, Merlo CA, Baumgartner WA,
Cameron D,
et al
. STS risk score predicts hospital charges and resource
use after AVR.
J Thorac Cardiovasc Surg
2011;
142
: 650–655.
26. Toumpoulis IK, Anagnostopoulos CE. Does EuroScore predict length
of stay and specific postoperative complications after cardiac surgery?
E J Computer Sci
2005;
27
(1): 128–133.
